1-6 of 6
clams
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Comparison of Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome Treated on Versus Off Study

Sarah A. Buckley, MD, Mary-Elizabeth M. Percival, MD, Megan Othus, PhD, Anna B. Halpern, MD, Emily M Huebner, Carole Shaw, Paul C. Hendrie, MD PhD, Mazyar Shadman, MD MPH, Pamela S. Becker, MD PhD, Roland B. Walter, MD PhD, Elihu H. Estey, MD
Journal: Blood
Blood (2016) 128 (22): 2787.
https://doi.org/10.1182/blood.V128.22.2787.2787
Published: 2016
Journal Articles

A Phase 1/2 Study of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Anna B. Halpern, MD, Megan Othus, PhD, Emily M Huebner, Kaysey F. Orlowski, Bart L. Scott, MD, Heather A. Smith, PA-C, Pamela S. Becker, MD PhD, Mary-Elizabeth M. Percival, MD, Paul C. Hendrie, MD PhD, Andrea M. Perdue, PA-C, Tara L. Chen, PharmD, BCOP, Sarah A. Buckley, MD, Harry P. Erba, MD PhD, Elihu H. Estey, MD, Roland B. Walter, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1068.
https://doi.org/10.1182/blood.V128.22.1068.1068
Published: 2016
Journal Articles

Cladribine, Cytarabine and Mitoxantrone As Treatment Intensification for Patients with Acute Myeloid Leukemia with the Excess of Bone Marrow Blasts on Day 14 of the First Induction. Prospective, Multicenter Study By the Polish Adult Leukemia Group (PALG)

Agnieszka Pluta, MD PhD, Kamil Brzozowski, MD, Konrad Stepka, MD, Ewa Wawrzyniak, PhD, Anna Krawczynska, PhD, Anna Szmigielska-Kaplon, MD PhD, Olga Grzybowska-Izydorczyk, Magdalena Czemerska, MD PhD, Tomasz Gromek, MD PhD, Marek Hus, MD PhD, Grzegorz Helbig, MD PhD, Ewa Bodzenta, MD PhD, Sebastian Grosicki, MD PhD, Malgorzata Razny, MD PhD, Lukasz Bolkun, MD PhD, Janusz Kloczko, MD PhD, Wanda Knopinska-Posluszny, MD PhD, Agnieszka Piekarska, MD PhD, Andrzej Hellmann, MD PhD, Marta Sobas, MD PhD, Tomasz Wrobel, MD PhD, Elzbieta Patkowska, Ewa Lech-Maranda, MD PhD, Krzysztof Warzocha, Jerzy Holowiecki, MD PhD, Sebastian Giebel, Tadeusz Robak, MD PhD, Agnieszka Wierzbowska, MD PhD
Journal: Blood
Blood (2016) 128 (22): 213.
https://doi.org/10.1182/blood.V128.22.213.213
Published: 2016
Journal Articles

Phase 1 Trial of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)

Asma Anwar, MD, Anna B. Halpern, MD, Megan Othus, PhD, Bart L. Scott, MD, Paul C. Hendrie, MD PhD, Pamela S. Becker, MD PhD, Andrea M. Perdue, PA-C, Heather A. Smith, PA-C, Tara L. Chen, PharmD, Sarah A. Buckley, MD, Kaysey F. Orlowski, Morgan A. Powell, BS, Elihu H. Estey, MD, Roland B. Walter, MD PhD MS
Journal: Blood
Blood (2015) 126 (23): 1339.
https://doi.org/10.1182/blood.V126.23.1339.1339
Published: 2015
Journal Articles

A Phase I Study Of Azacitidine After Donor Lymphocyte Infusion For Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation

Armin Ghobadi, MD, Mark A. Fiala, BS, CCRP, Camille N. Abboud, MD, Amanda F Cashen, MD, Linda Eissenberg, PhD, Timothy Graubert, MD, Meagan A Jacoby, MD/PhD, Iskra Pusic, MD, Mark A. Schroeder, MD, Keith E. Stockerl-Goldstein, MD, Michael H. Tomasson, MD, Geoffrey L. Uy, MD, Ravi Vij, MD, Matthew J. Walter, MD, John F. DiPersio, MD, PhD, Peter Westervelt, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3320.
https://doi.org/10.1182/blood.V122.21.3320.3320
Published: 2013
Journal Articles

Cladribine in the Treatment of Acute Myeloid Leukemia

Michael G. Martin, MD, John S. Welch, MD, PhD, Kristan Augustin, PharmD, Lindsay Hladnik, PharmD, Camille N. Abboud, MD, FACP
Journal: Blood
Blood (2008) 112 (11): 4032.
https://doi.org/10.1182/blood.V112.11.4032.4032
Published: 2008